JP2024023059A5 - - Google Patents

Download PDF

Info

Publication number
JP2024023059A5
JP2024023059A5 JP2022126613A JP2022126613A JP2024023059A5 JP 2024023059 A5 JP2024023059 A5 JP 2024023059A5 JP 2022126613 A JP2022126613 A JP 2022126613A JP 2022126613 A JP2022126613 A JP 2022126613A JP 2024023059 A5 JP2024023059 A5 JP 2024023059A5
Authority
JP
Japan
Prior art keywords
virus
methoxybutanol
methyl
ether
mass
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022126613A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024023059A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2022126613A priority Critical patent/JP2024023059A/ja
Priority claimed from JP2022126613A external-priority patent/JP2024023059A/ja
Publication of JP2024023059A publication Critical patent/JP2024023059A/ja
Publication of JP2024023059A5 publication Critical patent/JP2024023059A5/ja
Pending legal-status Critical Current

Links

JP2022126613A 2022-08-08 2022-08-08 ウイルス不活化剤 Pending JP2024023059A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022126613A JP2024023059A (ja) 2022-08-08 2022-08-08 ウイルス不活化剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2022126613A JP2024023059A (ja) 2022-08-08 2022-08-08 ウイルス不活化剤

Publications (2)

Publication Number Publication Date
JP2024023059A JP2024023059A (ja) 2024-02-21
JP2024023059A5 true JP2024023059A5 (enExample) 2025-06-30

Family

ID=89930561

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022126613A Pending JP2024023059A (ja) 2022-08-08 2022-08-08 ウイルス不活化剤

Country Status (1)

Country Link
JP (1) JP2024023059A (enExample)

Similar Documents

Publication Publication Date Title
RU2015130634A (ru) Композиция назальной вакцины против гриппа
Lin et al. The inhibition of H1N1 influenza virus-induced apoptosis by silver nanoparticles functionalized with zanamivir
Liang et al. Inhalable dry powder formulations of siRNA and pH-responsive peptides with antiviral activity against H1N1 influenza virus
JP2009524509A5 (enExample)
JP5697126B2 (ja) 抗ウィルス剤
CN102038725B (zh) 包含漆树提取物的预防流感病毒感染的组合物、包含该组合物的空气过滤器和包含该过滤器的空气净化装置
MXPA04004730A (es) Composiciones farmaceuticas en forma particulada.
JPWO2020017619A5 (enExample)
JP2024023059A5 (enExample)
JP5208151B2 (ja) ヌルデ抽出物を含むインフルエンザウイルス感染の予防用組成物、該組成物を含むエアフィルター、及び該フィルターを含む空気清浄器
HRP20221194T1 (hr) Beta-ukosnica peptidomimetik s inhibitorskom aktivnošću elastase i njegovi oblici doziranja aerosolom
JP2002526400A5 (enExample)
RU2017101987A (ru) Риновакцинационная система для вакцины против гриппа
JP2022164624A5 (enExample)
CN104026150B (zh) 一种预防和杀灭禽流感病毒的复合液及其制备方法和应用
Tavakoli et al. Nanostructures for the Prevention, Diagnosis, and Treatment of COVID‐19: A Review
KR101434788B1 (ko) 천연추출물을 이용한 항바이러스 기능을 갖는 필터의 제조방법
JP2015117197A (ja) 鼻症状改善剤
CN108289728A (zh) 在牙齿上形成均匀的美化涂层或治疗性涂层的方法
US3730182A (en) Method of delivery of solution to skin having substantial amounts of hair thereon
KR20130083301A (ko) 방향제 및 그 제조방법
JP5283906B2 (ja) 局所製剤に使用するための親水性ビーズ
JP2022164624A (ja) 液噴霧用ウイルス不活化組成物
JP6155435B2 (ja) 抗ウイルス剤とその使用方法
JP7442833B2 (ja) 抗菌方法